Starling Oncology

STLNWNasdaq United States Health Care Medical/Nursing Services

Market cap

$3.954 M

$0.04 +0.00%

Close of 7 Oct 2026

As of 7 Oct 2026, Starling Oncology (STLNW) has a market capitalization of $3.95M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$502.7M

#1898 by revenue

Earnings

$60.6B

#8 by earnings

Shares outstanding

101,916,115

Latest filing cover page

P/E ratio

0.0

Cap ÷ net income

Other share classes

Starling Oncology lists more than one class of stock. Company figures above cover all classes combined.

STLN

Insiders buying

All insider buying →

One open-market purchase by officers and directors of Starling Oncology, worth $78.5K. Grants and option exercises are excluded.

Jorey Chernett$78.5K
12,000 shares at $6.54 on 14 Aug 2026 · filed 17 Aug 2026

Where these numbers come from

Share counts and financials for Starling Oncology are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 8 Oct 2026. Read the methodology.